首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2783480篇
  免费   198174篇
  国内免费   6732篇
耳鼻咽喉   39394篇
儿科学   88399篇
妇产科学   78529篇
基础医学   394490篇
口腔科学   82152篇
临床医学   245366篇
内科学   535293篇
皮肤病学   64220篇
神经病学   217864篇
特种医学   108630篇
外国民族医学   659篇
外科学   423536篇
综合类   63944篇
一般理论   989篇
预防医学   201526篇
眼科学   67727篇
药学   208907篇
  9篇
中国医学   7590篇
肿瘤学   159162篇
  2019年   21639篇
  2018年   30840篇
  2017年   23846篇
  2016年   27004篇
  2015年   31657篇
  2014年   43429篇
  2013年   63201篇
  2012年   86787篇
  2011年   90843篇
  2010年   53909篇
  2009年   50217篇
  2008年   83178篇
  2007年   89023篇
  2006年   88918篇
  2005年   85541篇
  2004年   82330篇
  2003年   78228篇
  2002年   75586篇
  2001年   132598篇
  2000年   135550篇
  1999年   113080篇
  1998年   29618篇
  1997年   26027篇
  1996年   25521篇
  1995年   25811篇
  1994年   23791篇
  1993年   22124篇
  1992年   86932篇
  1991年   84607篇
  1990年   81967篇
  1989年   79310篇
  1988年   72924篇
  1987年   71692篇
  1986年   68071篇
  1985年   64711篇
  1984年   48180篇
  1983年   41028篇
  1982年   23941篇
  1979年   44588篇
  1978年   31393篇
  1977年   26949篇
  1976年   24679篇
  1975年   27199篇
  1974年   32654篇
  1973年   31680篇
  1972年   29900篇
  1971年   27842篇
  1970年   26134篇
  1969年   24762篇
  1968年   23280篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen.  相似文献   
3.
4.
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty.  相似文献   
5.
6.
7.
Pharmaceutical Research - The quality testing and approval procedure for most pharmaceutical products is a streamlined process with standardized procedures for the determination of critical quality...  相似文献   
8.
Graefe's Archive for Clinical and Experimental Ophthalmology - To investigate comorbidities and medications associated with acute (ASCH) and delayed (DSCH) suprachoroidal hemorrhage (SCH), and...  相似文献   
9.
Graefe's Archive for Clinical and Experimental Ophthalmology - The purpose was to ascertain if any relation exists between the elevated intraocular pressure (IOP) in patients with...  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号